Immunome
Presence
Immunome is a company listed under the stock ticker IMNM (US).
Executives
View the org chart displaying its 20 main executives
Most searched biographies at Immunome
- Purnanand Sarma, Director, President and Chief Executive Officer
- Philip Wagenheim, Director
- Clay Siegall, Chairman of the Board
Popular executive movements at Immunome
- Phil Roberts has joined the company as Chief Technical Officer (posted on January 5 2024).
- Carol Schafer has joined the company as Director (posted on January 3 2024).
- Max Rosett who is Senior Vice President, Operations, will be promoted to Interim Chief Financial Officer and Principal Financial Officer on Apr. 1, 2024 (posted on January 3 2024).
Click here to view some more movements at Immunome
Create your alert
to follow the executive moves at Immunome.
Biotechnology
Immunome has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Immunome
Social media about Immunome
- Immunome on Wikipedia, Google News & Yahoo Finance
- Immunome on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Purnanand Sarma 
